The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral neuropathy lawsuits involving Avelox, Cipro, and Levaquin are a part of the multidistrict litigation 2642 in the U.S. District Court, District of Minnesota. January 19, 2018, is the deadline for completion of case-specific discovery for Avelox-only and Cipro-only cases. As of today, the bellwether trials begin from November 2018 for the Avelox-only cases and from March 4, 2019, for the Cipro-only cases
Recent News
Roundup Lawsuits in New Jersey Seek Centralization
03/04/2024 - 17:33
A request has been filed by a group of plaintiffs urging the consolidation of all Roundup lawsuits related to non-Hodgkin’s lymphom…
Learn More
Baltimore Settles in Walmart Opioid Cases
03/03/2024 - 20:48
The mayor of Baltimore, representing the City, has endorsed a statewide settlement with Walmart to address the corporation's allege…
Learn More
Opioid Crisis: Fentanyl and Meth Drive 'Fourth Wave…
02/27/2024 - 21:02
The United States is currently grappling with what some experts identify as the "fourth wave" of the opioid epidemic, presenting in…
Learn More
Oregon Re-evaluates Decriminalization Amid Opioid Crisis
02/20/2024 - 16:46
In 2020, Oregonians approved a groundbreaking ballot measure, known as Measure 110, establishing the most progressive drug law in t…
Learn More